Prospective study for the presence of small intestine lesion using capsule endoscopy in patient with immune fecal occult blood-positive.
Not Applicable
- Conditions
- Patient with immune fecal occult blood-positive
- Registration Number
- JPRN-UMIN000008603
- Lead Sponsor
- Kanazawa Medical University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
Not provided
Exclusion Criteria
1)At their own request of resignation or withdrawal of informed consent. 2)It was found that patients do not satisfy the criteria after entry. 3)Stop of this study. 4)Patients who are considered to be inapproriate by the investigators.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The presence of small intestine lesion in patient with immune fecal occult blood-positive.
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie immune fecal occult blood positivity in small intestine lesions detected by capsule endoscopy?
How does capsule endoscopy compare to traditional endoscopy in diagnosing small intestine lesions in iFOBT-positive patients?
Which biomarkers correlate with lesion detection rates in JPRN-UMIN000008603's iFOBT-positive cohort using capsule endoscopy?
What adverse events are reported with capsule endoscopy in iFOBT-positive patients and how are they managed?
Are there combination diagnostic approaches with capsule endoscopy for iFOBT-positive small intestine pathology in clinical trials?